A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma
Phase 1/2 Completed
31 enrolled
Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Phase 1/2 Completed
12 enrolled 9 charts
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Phase 1/2 Completed
47 enrolled 36 charts
GEMMK
Phase 1/2 Completed
25 enrolled 15 charts
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Phase 1/2 Completed
803 enrolled 2 FDA
TARMIC
Phase 1/2 Completed
50 enrolled 15 charts
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.
Phase 1/2 Completed
28 enrolled
IACE-OS
Phase 1/2 Completed
10 enrolled
U01CA236220
Phase 1/2 Completed
37 enrolled
LEADER
Phase 1/2 Completed
30 enrolled 9 charts
TRuST
Phase 1/2 Completed
58 enrolled
Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1/2 Completed
60 enrolled
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
Phase 1/2 Completed
245 enrolled
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
Phase 1/2 Completed
316 enrolled
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Phase 1/2 Completed
107 enrolled 7 charts
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
Phase 1/2 Completed
21 enrolled
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
Phase 1/2 Completed
51 enrolled 32 charts
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
Phase 1/2 Completed
116 enrolled 31 charts
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Dendritic Cell Vaccination for Patients with Solid Tumors
Phase 1/2 Completed
48 enrolled
Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma
Phase 1/2 Completed
8 enrolled
Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases
Phase 1/2 Completed
36 enrolled
ImmunoSarc
Phase 1/2 Completed
197 enrolled
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
Phase 1/2 Completed
27 enrolled 10 charts
Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors
Phase 1/2 Completed
26 enrolled 20 charts
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Phase 1/2 Completed
36 enrolled
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Phase 1/2 Completed
25 enrolled 11 charts
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
Phase 1/2 Completed
13 enrolled 17 charts
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
203 enrolled
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Phase 1/2 Completed
160 enrolled 21 charts
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)
Phase 1/2 Completed
15 enrolled
Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Phase 1/2 Completed
PRE-FURTHER
Phase 1/2 Completed
10 enrolled
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Phase 1/2 Completed
140 enrolled 23 charts
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Phase 1/2 Completed
76 enrolled 25 charts
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Phase 1/2 Completed
64 enrolled 29 charts
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
Phase 1/2 Completed
117 enrolled 32 charts
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
Phase 1/2 Completed
153 enrolled
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
Phase 1/2 Completed
65 enrolled 21 charts
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1/2 Completed
46 enrolled
To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue
Phase 1/2 Completed
16 enrolled
A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor
Phase 1/2 Completed
65 enrolled
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Phase 1/2 Completed
58 enrolled 18 charts
MSC11FCD-GBM
Phase 1/2 Completed
10 enrolled
PDR001 Plus Imatinib for Metastatic or Unresectable GIST
Phase 1/2 Completed
39 enrolled
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
Pomalidomide for Kaposi Sarcoma in People With or Without HIV
Phase 1/2 Completed
28 enrolled 23 charts
GemTax
Phase 1/2 Completed
37 enrolled 17 charts
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
125 enrolled 12 charts